2016
DOI: 10.1016/j.canrad.2016.05.016
|View full text |Cite
|
Sign up to set email alerts
|

Organisation française de la radiothérapie pédiatrique : résultats d’une enquête du comité radiothérapie de la Société française des cancers de l’enfant (SFCE)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…Although paediatric and radiation oncologists are the most knowledgeable healthcare providers, when it comes to late sequelae of cancer therapy in children, due to time constraints it is currently impossible for them to provide life-long monitoring, even though most radiation oncologists are adult practitioners. 45 In several healthcare systems, the GP can be a good point of contact to promote follow-up care, advise patients on lifestyle choices, and carry out surveillance of late health problems and comorbidities. However, given the complexity of diagnosis and treatment-specific late side effects, patients should be provided with current and relevant information about the risks and recommendations for follow-up care and new knowledge about late side effects of cancer therapy as soon as it becomes available.…”
Section: Discussionmentioning
confidence: 99%
“…Although paediatric and radiation oncologists are the most knowledgeable healthcare providers, when it comes to late sequelae of cancer therapy in children, due to time constraints it is currently impossible for them to provide life-long monitoring, even though most radiation oncologists are adult practitioners. 45 In several healthcare systems, the GP can be a good point of contact to promote follow-up care, advise patients on lifestyle choices, and carry out surveillance of late health problems and comorbidities. However, given the complexity of diagnosis and treatment-specific late side effects, patients should be provided with current and relevant information about the risks and recommendations for follow-up care and new knowledge about late side effects of cancer therapy as soon as it becomes available.…”
Section: Discussionmentioning
confidence: 99%